Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Erickson

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Toxicology Letters|December 1, 1991
Cocaine immunotoxicity: abnormal cytokine production in Hispanic drug usersG J Chen, R Pillai, J R Erickson, et al.
Techniques in Urology|August 24, 1999
Tolterodine for overactive bladder: time to onset of action, preferred dosage, and 9-month follow-upA Atan, B R Konety, J R Erickson, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 12, 1998
Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surfaceP A Pemberton, A R Tipton, N Pavloff, et al.
The Journal of Biological Chemistry|January 27, 1998
Edg-2/Vzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acidJ R Erickson, J J Wu, J G Goddard, et al.
Prostaglandins & Other Lipid Mediators|April 28, 2001
Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient managementJ R Erickson, Y Hasegawa, X Fang, et al.
The Biochemical Journal|November 4, 2000
Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinaseX Fang, S Yu, R LaPushin, et al.
Advances in Experimental Medicine and Biology|February 10, 2000
Determinants of receptor subtype specificity in the LPA-like lipid mediator familyG Tigyi, D J Fisher, K Lilion, et al.
Molecular Pharmacology|December 18, 1998
Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypesD J Fischer, K Liliom, Z Guo, et al.
The Journal of Biological Chemistry|June 5, 1998
Identification of a novel growth factor-like lipid, 1-O-cis-alk-1'-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparationsK Liliom, D J Fischer, T Virág, et al.
Pediatrics|January 31, 1998
Modulation of the immune system by human milk and infant formula containing nucleotidesL K Pickering, D M Granoff, J R Erickson, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Toxicology Letters|December 1, 1991
Cocaine immunotoxicity: abnormal cytokine production in Hispanic drug usersG J Chen, R Pillai, J R Erickson, et al.
Techniques in Urology|August 24, 1999
Tolterodine for overactive bladder: time to onset of action, preferred dosage, and 9-month follow-upA Atan, B R Konety, J R Erickson, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 12, 1998
Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surfaceP A Pemberton, A R Tipton, N Pavloff, et al.
The Journal of Biological Chemistry|January 27, 1998
Edg-2/Vzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acidJ R Erickson, J J Wu, J G Goddard, et al.
Prostaglandins & Other Lipid Mediators|April 28, 2001
Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient managementJ R Erickson, Y Hasegawa, X Fang, et al.
The Biochemical Journal|November 4, 2000
Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinaseX Fang, S Yu, R LaPushin, et al.
Advances in Experimental Medicine and Biology|February 10, 2000
Determinants of receptor subtype specificity in the LPA-like lipid mediator familyG Tigyi, D J Fisher, K Lilion, et al.
Molecular Pharmacology|December 18, 1998
Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypesD J Fischer, K Liliom, Z Guo, et al.
The Journal of Biological Chemistry|June 5, 1998
Identification of a novel growth factor-like lipid, 1-O-cis-alk-1'-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparationsK Liliom, D J Fischer, T Virág, et al.
Pediatrics|January 31, 1998
Modulation of the immune system by human milk and infant formula containing nucleotidesL K Pickering, D M Granoff, J R Erickson, et al.
Pageof 4